Singapore’s HSA approves vericiguat (Verquvo) for use in high-risk heart failure patients with reduced ejection fractionBy KayeDecember 16, 20210 Background Heart failure (HF) is a significant health problem with a prevalence of 4.5% in Singapore, and over 26 million…
Heart Failure: An Insight To Its Causes And TreatmentBy Sunitha SSeptember 29, 20210 Heart failure is a leading cause of mortality all over the world. It is estimated that around 64.3 million people…
